Parul University Digital Repository

Development and validation of analytical method for simultaneous estimation of eperisone hydrochloride and diclofenac sodium in bulk and solid dosage form

Show simple item record

dc.contributor.author Bhatt, Divyangkumar
dc.date.accessioned 2020-11-09T08:51:56Z
dc.date.available 2020-11-09T08:51:56Z
dc.date.issued 2013-05-01
dc.identifier.uri http://ir.paruluniversity.ac.in:8080/xmlui/handle/123456789/7459
dc.description For Full Thesis Kindly contact to respective Library en_US
dc.description.abstract A simple, accurate and precise UV Spectrophotometric methods and RP-HPLC method was developed and validated for simultaneous estimation of Eperisone Hydrochloride and Diclofenac Sodium in bulk and solid dosage form. In Q-absorbance ratio method determination was carried out at 256 nm λmax of Eperisone Hydrochloride and 269 nm an Isobestic point of both the drug. The linearity range was observed between 2-20 μg/ml for both Eperisone hydrochloride and Diclofenac Sodium at their respective wavelengths for both methods. Both the drugs were found in good agreement with the labelled claim in the marketed formulation. In capsule dosage form Eperisone Hydrochloride and Diclofenac Sodium were estimated 101.44 ±0.55 & 101.31±0.97 %. respectively. Second developed UV method was Area under Curve. The method involved the measurement of area at selected analytical wavelength ranges and performing the analysis using “Cramer’s Rule”. Two analytical wavelength ranges selected were A simple, accurate and precise UV Spectrophotometric methods and RP-HPLC method was developed and validated for simultaneous estimation of Eperisone Hydrochloride and Diclofenac Sodium in bulk and solid dosage form. In Q-absorbance ratio method determination was carried out at 256 nm λmax of Eperisone Hydrochloride and 269 nm an Isobestic point of both the drug. The linearity range was observed between 2-20 μg/ml for both Eperisone hydrochloride and Diclofenac Sodium at their respective wavelengths for both methods. Both the drugs were found in good agreement with the labelled claim in the marketed formulation. In capsule dosage form Eperisone Hydrochloride and Diclofenac Sodium were estimated 101.44 ±0.55 & 101.31±0.97 %. respectively. Second developed UV method was Area under Curve. The method involved the measurement of area at selected analytical wavelength ranges and performing the analysis using “Cramer’s Rule”. Two analytical wavelength ranges selected were en_US
dc.language.iso en en_US
dc.publisher Parul University en_US
dc.subject 112140813003] en_US
dc.title Development and validation of analytical method for simultaneous estimation of eperisone hydrochloride and diclofenac sodium in bulk and solid dosage form en_US
dc.title.alternative 112140813003 en_US
dc.type Thesis en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account